Should Metformin Be Our Antiglycemic Agent of Choice Post-transplantation?
Adnan Sharif(Queen Elizabeth Hospital Birmingham)
Cited by 68
Related Papers
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
|American Journal of Transplantation|2014|522
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans
|Journal of Clinical Investigation|2010|516
Comparison of organ donation and transplantation rates between opt-out and opt-in systems
|Kidney International|2019|282
Malignancy-related mortality following kidney transplantation is common
|Kidney International|2013|149